| Contact Us | About UsAdvertisement | 
Weather Forecast

Meda acquires rights to Nalox in Europe

Monday, 19 September 2011
Meda has acquired exclusive licensing rights to Nalox (treatment of fungal nail infections/nail psoriasis) from Moberg Derma AB.

Within a short time span, Meda has established Nalox as the market leader in the Nordic region. The new agreement covers several major European countries, such as Germany, France, the UK, Spain, Austria, the Netherlands and Belgium.
Bases on press release

Leading stocks

ForexProsThe Leading Stocks Quotes Powered by Forexpros - The Leading Financial Portal.